SI

Sofinnova Investments Portfolio holdings

AUM $1.47B
1-Year Return 17.43%
This Quarter Return
+12.51%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.47B
AUM Growth
+$144M
Cap. Flow
+$51.7M
Cap. Flow %
3.52%
Top 10 Hldgs %
55.99%
Holding
73
New
9
Increased
18
Reduced
18
Closed
13

Top Buys

1
GILD icon
Gilead Sciences
GILD
$70M
2
ABBV icon
AbbVie
ABBV
$49.3M
3
BSX icon
Boston Scientific
BSX
$46.3M
4
LLY icon
Eli Lilly
LLY
$34.5M
5
UTHR icon
United Therapeutics
UTHR
$34.1M

Top Sells

1
SYK icon
Stryker
SYK
$111M
2
MDT icon
Medtronic
MDT
$50.6M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
$47.6M
4
BPMC
Blueprint Medicines
BPMC
$23.1M
5
BMY icon
Bristol-Myers Squibb
BMY
$22.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NTRA icon
1
Natera
NTRA
$23.1B
$262M 16.02%
1,550,280
– –
GILD icon
2
Gilead Sciences
GILD
$143B
$116M 7.12%
1,050,308
+631,408
+151% +$70M
LLY icon
3
Eli Lilly
LLY
$652B
$75.6M 4.63%
97,018
+44,218
+84% +$34.5M
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$7.86B
$73.7M 4.51%
694,096
+184,046
+36% +$19.5M
VERA icon
5
Vera Therapeutics
VERA
$1.54B
$65.8M 4.03%
2,793,987
– –
ABBV icon
6
AbbVie
ABBV
$375B
$49.3M 3.02%
+265,850
New +$49.3M
BSX icon
7
Boston Scientific
BSX
$159B
$46.3M 2.83%
+431,200
New +$46.3M
DXCM icon
8
DexCom
DXCM
$31.6B
$45.7M 2.8%
523,694
+127,719
+32% +$11.1M
IDYA icon
9
IDEAYA Biosciences
IDYA
$2.38B
$45.1M 2.76%
2,147,795
-474,397
-18% -$9.97M
BBIO icon
10
BridgeBio Pharma
BBIO
$10.2B
$42.9M 2.62%
993,093
+258,866
+35% +$11.2M
ISRG icon
11
Intuitive Surgical
ISRG
$167B
$38.4M 2.35%
70,642
+58,658
+489% +$31.9M
RYTM icon
12
Rhythm Pharmaceuticals
RYTM
$6.78B
$37M 2.26%
586,010
+139,171
+31% +$8.79M
AVBP icon
13
ArriVent BioPharma
AVBP
$819M
$36.9M 2.26%
1,696,752
– –
ROIV icon
14
Roivant Sciences
ROIV
$8.82B
$34.8M 2.13%
3,088,814
+1,809,304
+141% +$20.4M
SLNO icon
15
Soleno Therapeutics
SLNO
$3.71B
$34.8M 2.13%
415,219
-69,252
-14% -$5.8M
UTHR icon
16
United Therapeutics
UTHR
$18.1B
$34.1M 2.08%
+118,513
New +$34.1M
INSM icon
17
Insmed
INSM
$30.7B
$31.6M 1.93%
313,923
+9,669
+3% +$973K
AKRO icon
18
Akero Therapeutics
AKRO
$3.58B
$29.3M 1.79%
548,788
+38,768
+8% +$2.07M
SUPN icon
19
Supernus Pharmaceuticals
SUPN
$2.58B
$25.2M 1.54%
799,253
+278,575
+54% +$8.78M
ANAB icon
20
AnaptysBio
ANAB
$613M
$22.9M 1.4%
1,032,362
-127,671
-11% -$2.83M
RAPP
21
Rapport Therapeutics
RAPP
$524M
$22.7M 1.39%
1,995,594
– –
QURE icon
22
uniQure
QURE
$985M
$21.7M 1.33%
1,558,356
+1,012,585
+186% +$14.1M
MRUS icon
23
Merus
MRUS
$5.1B
$21.3M 1.3%
+404,562
New +$21.3M
AZN icon
24
AstraZeneca
AZN
$253B
$20.5M 1.26%
+293,661
New +$20.5M
PTCT icon
25
PTC Therapeutics
PTCT
$4.55B
$18.4M 1.12%
375,939
-203,400
-35% -$9.93M
1
2 3